November 21, 2019
CRISPR Therapeutics Initiates $275 Million Public Offering
Read More
November 20, 2019
Reata Raises $505 Million to Advance Rare Disease Drugs
Read More
November 13, 2019
Avidity Raises $100 Million to Advance Treatments for Rare Muscle Disorders
Read More
November 7, 2019
Centogene Raises $56 Million in IPO for Rare Disease Diagnostics
Read More
November 7, 2019
Arkuda Therapeutics Raises $44 Million to Treat Rare Form of Dementia
Read More
October 25, 2019
Cabaletta Bio Raises $75 Million in IPO for T-Cell Therapies for Autoimmune Diseases
Read More
October 21, 2019
ProQR, Rhythm Complete Public Offerings
Read More
October 16, 2019
AI Drug Developer Healx Secures $56 million to Launch Global Rare Disease Accelerator Program
Read More
October 4, 2019
Aeovian Raises $37 Million to Advance Therapy for Rare CNS Disease
Read More
September 18, 2019
Versantis Raises $16.1 Million to Develop Treatment for Liver Disease Including ACLF
Read More
September 16, 2019
SpringWorks Raises $162 Million in IPO
Read More
September 12, 2019
Pharvaris Raises $66 Million to Advance Oral Therapy for Hereditary Angioedema
Read More
Load More
X